Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 2:48 pm Sale | 13G | INTELLIPHARMACEUTICS INTL INC IPCI | ARMISTICE CAPITAL LLC | 0 0% | -575,099 (Position Closed) | View |
| 2023-02-14 1:01 pm Unchanged | 13G | INTELLIPHARMACEUTICS INTL INC IPCI | ARMISTICE CAPITAL LLC | 3,672,877 9.99% | 0 (Unchanged) | View |
| 2022-02-14 6:38 pm Purchase | 13G | INTELLIPHARMACEUTICS INTL INC IPCI | ARMISTICE CAPITAL LLC | 3,672,877 9.99% | 1,044,899 (+39.76%) | View |
| 2021-02-16 5:06 pm Sale | 13G | INTELLIPHARMACEUTICS INTL INC IPCI | ARMISTICE CAPITAL LLC | 2,627,978 9.99% | -5,599,522 (-68.06%) | View |
| 2020-02-11 07:00 am Unchanged | 13G | INTELLIPHARMACEUTICS INTL INC IPCI | UBS Group AG UBS | 0 0% | 0 (Unchanged) | View |
| 2020-01-21 1:53 pm Sale | 13G | INTELLIPHARMACEUTICS INTL INC IPCI | SABBY MANAGEMENT LLC | 1,101,571 11% | -843,407 (-43.36%) | View |
| 2019-11-18 5:03 pm Purchase | 13D | INTELLIPHARMACEUTICS INTL INC IPCI | Intellipharmaceutics International Inc. | 5,338,519 19.89% | 5,338,519 (New Position) | View |